Delivery Order SPE2DB22D1202-SPE2DB23FUET4
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $23,180.97, is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 27, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICK, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $56,647.25 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a period of performance through May 3, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,352.40 for the pharmaceutical product ENBREL 50 MG/ML SURECLICK. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on October 27, 2021, with an ultimate completion date of October 28, 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $8,400.82 for Enbrel 50 mg/ml SureClick medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 26, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) worth...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,831.96 for the supply of ENBREL 50 MG/ML SURECLICKML. The contract, awarded by the Defense Logistics Agency (DLA), has a completion date of March 27, 2023 and is a firm fixed-price delivery order. The contract is not designated with a set-aside status. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of ENBREL 50 MG/ML SURECLICKML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA) and has a ceiling value of $76,794.03. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of December 8, 2022. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the supply of ENBREL 50 MG/ML SURECLICKML, a specialty pharmaceutical product. The $13,022.74 firm fixed-price delivery order contract has an ultimate completion date of January 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $50,404.92 for the supply of ENBREL 50 MG/ML SURECLICKML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of March 7, 2024. This DO is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the...
- This federal contract award is for the delivery of ENBREL 50 MG/ML SURECLICK to the Defense Logistics Agency (DLA). The contract, valued at $5,568.32, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 20, 2023. This contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $59,641.38 for the medical product ENBREL 50 MG/ML SURECLICK ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 2, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FUET4Delivery Order
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order for ENBREL 50 MG/ML SURECLICK medication awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $30,494.61 firm fixed-price contract has a completion date of September 27, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract award does not have a set-aside designation, indicating full and open competition. Through this and other IDCs, Amerisourcebergen Drug Corp demonstrates its capacity to meet the diverse pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.5k | 9/26/23 |